NADAC acquisition cost data for PHENAZOPYRIDINE 100 MG TAB. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 51293081001 | $0.3512 | 2022-08-17 | Rx |
| 42192080101 | $0.1938 | 2022-12-21 | Rx |
| 51293061101 | $0.1938 | 2022-12-21 | Rx |
| 58657045001 | $0.1938 | 2022-12-21 | Rx |
| 65162068110 | $0.1938 | 2022-12-21 | Rx |
| 69367016204 | $0.1938 | 2022-12-21 | Rx |
| 75826011410 | $0.1938 | 2022-12-21 | Rx |
| 42192080101 | $0.1938 | 2022-12-21 | Rx |
| 51293061101 | $0.1938 | 2022-12-21 | Rx |
| 58657045001 | $0.1938 | 2022-12-21 | Rx |
Generic: Phenazopyridine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $1.0M | 55,016 | 40,768 | $1.12 |
| 2020 | $730.5K | 34,950 | 25,694 | $1.23 |
| 2021 | $559.9K | 37,501 | 28,484 | $0.9335 |
| 2022 | $491.3K | 38,599 | 29,236 | $0.8266 |
| 2023 | $382.4K | 42,197 | 32,631 | $0.6004 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.